Stephen Delatte, MD
Plastic and Reconstructive Surgery · Lafayette, LANPI 1245253194
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,665 of the $3,441 with a category attached, or 77.5%. It is spread thinly across 13 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations.
Across 100 payments — averaging $34.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$765
- AbbVie$751
- Galderma Laboratories, L.p.$627
- Integra Lifesciences Corporation$361
- Tepha Inc$248
- TELA Bio, Inc.$153
- plus $535 from 7 others
What the payments were for
- Speaking & faculty fees$45013%
- Food & beverage$2,66577%
- Other$3269%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 13 | $765 |
| AbbVie(2 entities) | 54 | $751 |
| Galderma Laboratories, L.p. | 8 | $627 |
| Integra Lifesciences Corporation | 3 | $361 |
| Tepha Inc | 6 | $248 |
| TELA Bio, Inc. | 4 | $153 |
| Davol Inc. | 2 | $141 |
| Mentor Worldwide LLC | 4 | $134 |
| Sientra, Inc. | 1 | $131 |
| Baxter Healthcare | 1 | $40 |
| Getinge USA Sales, LLC | 2 | $37 |
| Johnson & Johnson | 1 | $33 |
| Motiva USA, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,441 in reported general payments places this provider in the 60th percentile of 45 plastic and reconstructive surgery providers in Louisiana.
See all plastic and reconstructive surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spironolactone | 11 | $305 |
| Doxycycline Hyclate | 12 | $283 |
| Montelukast Sodium | 22 | $134 |
| Cephalexin | 18 | $127 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $87 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $63 |
| Diazepam | 21 | $33 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Lafayette
- Darrell HendersonLafayette$64
- Louis MesLafayette$12
- Simeon WallShreveport$56K
- David JansenMetairie$12K
- Holly WallShreveport$11K
- John GusteMetairie$10K
- Omer KaymakcalanNew Orleans$10K
- Ravi TandonMetairie$9K
- Felix BoppMetairie$8K
- Suma MaddoxNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.